ArticleScientific reports2024

BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.

María-José Felgueres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.